Procedural and long-term outcomes of tunneled transvenous leads

IF 5.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Heart rhythm Pub Date : 2025-05-01 Epub Date: 2024-09-06 DOI:10.1016/j.hrthm.2024.08.063
Wissam Mekary MD, Rand Ibrahim MD, Stacy Westerman MD, Anand Shah MD, Neal K. Bhatia MD, Faisal M. Merchant MD, FHRS, Mikhael F. El-Chami MD, FHRS
{"title":"Procedural and long-term outcomes of tunneled transvenous leads","authors":"Wissam Mekary MD,&nbsp;Rand Ibrahim MD,&nbsp;Stacy Westerman MD,&nbsp;Anand Shah MD,&nbsp;Neal K. Bhatia MD,&nbsp;Faisal M. Merchant MD, FHRS,&nbsp;Mikhael F. El-Chami MD, FHRS","doi":"10.1016/j.hrthm.2024.08.063","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIEDs). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long-term outcomes remain unclear with this technique.</div></div><div><h3>Objective</h3><div>We sought to assess outcomes of tunneled transvenous leads.</div></div><div><h3>Methods</h3><div>We retrospectively identified all patients who underwent transvenous CIED lead tunneling to a contralateral pocket at our institution between 2014 and 2024. Clinical characteristics, indications for lead implantation, postoperative complications, and long-term outcomes were collected.</div></div><div><h3>Results</h3><div>We identified that 27 patients underwent transvenous lead tunneling at our institution. Most patients were men (20, 74%) with a mean age of 68.8 ± 18.3 years. Most patients had nonischemic cardiomyopathy (16, 59%) with a mean ejection fraction of 29.3% ± 11.3%. The tunneled leads were coronary sinus leads (20, 74%), followed by defibrillator leads (5, 18.5%) and right ventricular pacing leads (2, 7.4%). Implantation procedures were primarily for device upgrade (18), lead revisions (8), or de novo lead placement (1). No postoperative complications were seen. Patients were followed for a mean of 2.2 ± 1.4 years. One tunneled defibrillator lead (3.7%) had low shock impedance 3 years after implantation, which was monitored and did not require an intervention.</div></div><div><h3>Conclusion</h3><div>In patients with ipsilateral venous occlusion, contralateral lead tunneling appears to be an effective and safe approach to manage patients with CIEDs and occluded ipsilateral subclavian veins.</div></div>","PeriodicalId":12886,"journal":{"name":"Heart rhythm","volume":"22 5","pages":"Pages 1307-1311"},"PeriodicalIF":5.7000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Heart rhythm","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1547527124032892","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/6 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Lead-related venous stenosis and occlusion can complicate the insertion or replacement of transvenous leads in patients with cardiac implantable electronic devices (CIEDs). A possible solution is to tunnel the lead from the contralateral vasculature to the ipsilateral generator. Procedural complications and long-term outcomes remain unclear with this technique.

Objective

We sought to assess outcomes of tunneled transvenous leads.

Methods

We retrospectively identified all patients who underwent transvenous CIED lead tunneling to a contralateral pocket at our institution between 2014 and 2024. Clinical characteristics, indications for lead implantation, postoperative complications, and long-term outcomes were collected.

Results

We identified that 27 patients underwent transvenous lead tunneling at our institution. Most patients were men (20, 74%) with a mean age of 68.8 ± 18.3 years. Most patients had nonischemic cardiomyopathy (16, 59%) with a mean ejection fraction of 29.3% ± 11.3%. The tunneled leads were coronary sinus leads (20, 74%), followed by defibrillator leads (5, 18.5%) and right ventricular pacing leads (2, 7.4%). Implantation procedures were primarily for device upgrade (18), lead revisions (8), or de novo lead placement (1). No postoperative complications were seen. Patients were followed for a mean of 2.2 ± 1.4 years. One tunneled defibrillator lead (3.7%) had low shock impedance 3 years after implantation, which was monitored and did not require an intervention.

Conclusion

In patients with ipsilateral venous occlusion, contralateral lead tunneling appears to be an effective and safe approach to manage patients with CIEDs and occluded ipsilateral subclavian veins.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
隧道式经静脉导联的手术和长期疗效
背景:与导联相关的静脉狭窄和闭塞会使心脏植入式电子设备(CIED)患者的经静脉导联插入或更换复杂化。一种可能的解决方案是将导线从对侧血管穿至同侧发生器。这种技术的手术并发症和长期疗效仍不明确:我们试图评估隧道式经静脉导联的疗效:方法:我们回顾性地确定了 2014 年至 2024 年期间在本机构接受经静脉 CIED 导联隧道至对侧腔的所有患者。收集临床特征、导联植入适应症、术后并发症和长期疗效:我们发现有 27 名患者在本院接受了经静脉导联隧道植入术。大多数患者为男性(74%),平均年龄(68.8 ± 18.3)岁。大多数患者患有非缺血性心肌病(59%),平均射血分数为(29.3 ± 11.3)%。隧道导联是冠状窦导联(20 个),其次是除颤器导联(5 个)和 RV 起搏导联(2 个)。植入导联主要是为了设备升级(18 例)、导联翻新(8 例)或重新植入导联(1 例)。术后未出现并发症。患者平均接受了 2.2 ± 1.4 年的随访。有一个隧道式除颤器导联(3.7%)在植入3年后出现低冲击阻抗,经监测后无需干预:结论:对于同侧静脉闭塞的患者,对侧导联隧道植入术似乎是治疗同侧锁骨下静脉闭塞的 CIED 患者的一种有效而安全的方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Heart rhythm
Heart rhythm 医学-心血管系统
CiteScore
10.50
自引率
5.50%
发文量
1465
审稿时长
24 days
期刊介绍: HeartRhythm, the official Journal of the Heart Rhythm Society and the Cardiac Electrophysiology Society, is a unique journal for fundamental discovery and clinical applicability. HeartRhythm integrates the entire cardiac electrophysiology (EP) community from basic and clinical academic researchers, private practitioners, engineers, allied professionals, industry, and trainees, all of whom are vital and interdependent members of our EP community. The Heart Rhythm Society is the international leader in science, education, and advocacy for cardiac arrhythmia professionals and patients, and the primary information resource on heart rhythm disorders. Its mission is to improve the care of patients by promoting research, education, and optimal health care policies and standards.
期刊最新文献
Safety and efficacy of conduction system pacing in dual-chamber Pacemakers in a CRT-indicated population: Primary analysis of the CORE-CPP study. Characterization of a successful transseptal access with an electrified guidewire: An ex vivo ovine study. Marshall-plan ablation strategy for recurrent persistent atrial fibrillation in patients with durably isolated pulmonary veins. Cardiovascular-kidney-metabolic syndrome and atrial fibrillation: Insights from 2 real-world prospective registries across Europe and East Asia. Translational peak frequency mapping of human sinoatrial node-Bachmann bundle axis: Integrating human in vivo electroanatomic mapping with preclinical microstructural validation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1